Table 2 Patients’ background
All patients (n = 936) | No cancer (n = 487) | Cancer (n = 449) | p value | |
|---|---|---|---|---|
Age | <0.001 | |||
Mean (median) | 71 (71) | 69 (70) | 73 (73) | |
Range | 22–94 | 22–89 | 49–94 | |
PSA (ng/mL) | 0.008 | |||
Mean (median) | 58.5 (7.1) | 7.4 (5.8) | 114.0 (10.1) | |
Range | 0.3–16,920 | 0.3–83.6 | 0.6–16,920 | |
PV (mL) | <0.001 | |||
Mean (median) | 38.0 (33.2) | 43.6 (38.8) | 32.0 (28.1) | |
Range | 6–176 | 6–176 | 10–155 | |
PSAD (ng/mL/mL) | 0.005 | |||
Mean (median) | 1.99 (0.22) | 0.21 (0.15) | 3.94 (0.41) | |
Range | 0.0–480.7 | 0.0–3.1 | 0.0–480.7 | |
VBR (volume biopsy ratio) (mL/core) | <0.001 | |||
Mean (median) | 4.17 (3.89) | 4.50 (4.22) | 3.80 (3.64) | |
Range | 0.46–17.62 | 0.46–17.62 | 0.86–15.47 | |
Number of biopsy cores | <0.001 | |||
6 | 169 | 41 (24.3) | 128 (75.7) | |
8 | 331 | 161 (48.6) | 170 (51.4) | |
10 | 237 | 130 (54.9) | 107 (45.1) | |
12 | 199 | 155 (77.9) | 44 (22.1) | |
Gleason score, no (%) | ||||
≦6 | 143 | 143 (32.0) | ||
7 | 211 | 211 (47.2) | ||
8–10 | 93 | 93 (20.8) | ||